A detailed history of Key F Inancial Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Key F Inancial Inc holds 18,947 shares of ABT stock, worth $2.22 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
18,947
Previous 18,765 0.97%
Holding current value
$2.22 Million
Previous $1.95 Million 10.83%
% of portfolio
0.48%
Previous 0.47%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$100.07 - $118.13 $18,212 - $21,499
182 Added 0.97%
18,947 $2.16 Million
Q2 2024

Jul 29, 2024

BUY
$100.73 - $112.44 $302 - $337
3 Added 0.02%
18,765 $1.95 Million
Q1 2024

May 13, 2024

BUY
$109.52 - $120.96 $404,676 - $446,947
3,695 Added 24.52%
18,762 $2.13 Million
Q4 2023

Jan 31, 2024

BUY
$90.19 - $110.4 $25,343 - $31,022
281 Added 1.9%
15,067 $1.66 Million
Q3 2023

Nov 01, 2023

BUY
$95.53 - $114.62 $191 - $229
2 Added 0.01%
14,786 $1.43 Million
Q2 2023

Jul 28, 2023

BUY
$100.78 - $112.29 $7,659 - $8,534
76 Added 0.52%
14,784 $1.61 Million
Q1 2023

May 02, 2023

BUY
$96.86 - $114.01 $73,516 - $86,533
759 Added 5.44%
14,708 $1.49 Million
Q3 2022

Oct 28, 2022

BUY
$96.76 - $112.03 $508,473 - $588,717
5,255 Added 60.44%
13,949 $1.35 Million
Q1 2022

Apr 27, 2022

BUY
$114.02 - $139.04 $912 - $1,112
8 Added 0.09%
8,694 $1.03 Million
Q4 2021

Jan 19, 2022

BUY
$115.53 - $141.46 $50,371 - $61,676
436 Added 5.28%
8,686 $1.22 Million
Q2 2021

Aug 02, 2021

BUY
$105.79 - $124.53 $7,511 - $8,841
71 Added 0.87%
8,250 $998,000
Q1 2021

Apr 30, 2021

BUY
$108.84 - $128.23 $4,353 - $5,129
40 Added 0.49%
8,179 $980,000
Q2 2020

Aug 07, 2020

BUY
$76.57 - $98.0 $5,742 - $7,350
75 Added 0.93%
8,139 $724,000
Q1 2020

May 05, 2020

SELL
$62.82 - $91.86 $12,564 - $18,372
-200 Reduced 2.42%
8,064 $640,000
Q4 2019

Feb 11, 2020

BUY
$78.51 - $87.4 $648,806 - $722,273
8,264 New
8,264 $718,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Key F Inancial Inc Portfolio

Follow Key F Inancial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Key F Inancial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Key F Inancial Inc with notifications on news.